Sarepta Therapeutics | SRPT - 판매 수익





매상 변화 날짜
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Agios Pharmaceuticals USD 55.38M 10.64M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amgen USD 10.4B 300M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Daiichi Sankyo JPY 592.49B 17.75B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Gilead Sciences USD 8.3B 500M 2026-09
Incyte USD 1.56B 110M 2026-09
Insmed USD 524.42M 98.93M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Moderna USD 1.31M 98.69M 2026-09
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 16.6B 1.57B 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 14.44B 2.49B 2026-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09